Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Pollen Allergenic Extract [EPC]
Artemisia Absinthium Pollen is a non-standardized allergenic extract used primarily for the diagnosis and treatment of pollen-induced allergic rhinitis and asthma. It belongs to the class of pollen allergenic extracts used in immunotherapy.
Name
Artemisia Absinthium Pollen
Raw Name
ARTEMISIA ABSINTHIUM POLLEN
Category
Non-Standardized Pollen Allergenic Extract [EPC]
Drug Count
8
Variant Count
8
Last Verified
February 17, 2026
About Artemisia Absinthium Pollen
Artemisia Absinthium Pollen is a non-standardized allergenic extract used primarily for the diagnosis and treatment of pollen-induced allergic rhinitis and asthma. It belongs to the class of pollen allergenic extracts used in immunotherapy.
Detailed information about Artemisia Absinthium Pollen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Artemisia Absinthium Pollen.
Artemisia Absinthium Pollen, commonly derived from the plant known as Wormwood or Absinthe Wormwood, is utilized in clinical medicine as a non-standardized allergenic extract. This substance belongs to a pharmacological class known as Non-Standardized Pollen Allergenic Extracts [EPC]. Unlike standardized extracts, which have a potency measured in Bioequivalent Allergy Units (BAU), non-standardized extracts like Artemisia Absinthium are typically measured by weight/volume (w/v) or Protein Nitrogen Units (PNU). This distinction is critical for healthcare providers to understand when calculating dosages for immunotherapy.
The use of Artemisia Absinthium Pollen is primarily focused on two clinical areas: the diagnosis of allergic sensitivity through skin testing and the long-term management of allergic diseases through allergen immunotherapy (AIT). The FDA has historically regulated these extracts under the biologics framework, ensuring that the source materials are authentic and the manufacturing processes maintain consistent protein profiles, even if a universal potency standard has not yet been established for this specific species.
Artemisia Absinthium Pollen works through the principles of immunomodulation. In an allergic individual, exposure to the proteins found in the pollen triggers a Type I hypersensitivity reaction. This involves the cross-linking of allergen-specific Immunoglobulin E (IgE) antibodies bound to mast cells and basophils, leading to the release of inflammatory mediators like histamine and leukotrienes.
When used in immunotherapy (allergy shots), the extract is administered in gradually increasing doses. This process, known as desensitization, aims to shift the immune system's response from a Th2-dominated profile (allergic) to a Th1-dominated or T-regulatory (Treg) profile. Over time, this results in the production of 'blocking antibodies' (IgG4), which compete with IgE for allergen binding, and the suppression of the inflammatory cascade. At the molecular level, this reduces the recruitment of eosinophils to the respiratory mucosa and decreases the sensitivity of effector cells to subsequent environmental pollen exposure.
Artemisia Absinthium Pollen is FDA-indicated for the following clinical applications:
Off-label, it may occasionally be used in specialized research protocols investigating cross-reactivity between different Artemisia species, though this is not standard clinical practice.
Artemisia Absinthium Pollen is typically available in the following forms:
> Important: Only your healthcare provider can determine if Artemisia Absinthium Pollen is right for your specific condition. The selection of an allergenic extract must be based on a thorough clinical history and confirmed sensitivity.
Dosage for Artemisia Absinthium Pollen must be highly individualized based on the patient's sensitivity level and clinical response. There is no 'one-size-fits-all' dose.
Healthcare providers typically start with a very low dose, often 0.05 mL of a highly diluted solution (e.g., 1:100,000 w/v). Doses are increased weekly or bi-weekly by 25% to 50% until a maintenance dose is reached. The goal is to reach a dose that provides symptom relief without causing significant local or systemic reactions.
Once the maintenance dose is reached (often 0.5 mL of a 1:20 or 1:10 w/v concentration), the interval between injections is increased to every 2 to 4 weeks. This phase usually continues for 3 to 5 years to achieve long-term desensitization.
Artemisia Absinthium Pollen is generally considered safe for use in children, typically those aged 5 years and older. Dosing protocols follow the same build-up and maintenance logic as adult dosing, though healthcare providers may use more cautious increments for younger children. It is not typically recommended for children under the age of 5 due to the difficulty of communicating symptoms of a systemic reaction.
No specific dosage adjustments are required for patients with renal impairment, as the allergenic proteins are not cleared via traditional renal filtration mechanisms. However, the patient's overall health should be stable before administration.
No dosage adjustments are necessary for hepatic impairment. The metabolic processing of the extract is primarily mediated by immune cells and proteases.
Elderly patients may require more conservative dosing if they have underlying cardiovascular disease, which could increase the risk associated with the use of epinephrine if a systemic reaction occurs.
Artemisia Absinthium Pollen is administered exclusively by a healthcare professional in a clinical setting equipped to handle anaphylaxis.
If a dose is missed during the build-up phase, the healthcare provider may need to repeat the previous dose or even reduce the dose, depending on how much time has passed. If a maintenance dose is missed for more than 4-6 weeks, a dose reduction is usually required to ensure safety upon resumption.
An 'overdose' in the context of immunotherapy refers to the administration of a dose that exceeds the patient's current tolerance level. Signs include:
In the event of an overdose or systemic reaction, emergency measures including the administration of epinephrine, oxygen, and IV fluids must be initiated immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to self-administer these injections without medical guidance.
Most patients receiving Artemisia Absinthium Pollen immunotherapy will experience local reactions at the site of injection. These are generally considered a normal part of the immune response.
> Warning: Stop taking Artemisia Absinthium Pollen and call your doctor immediately if you experience any of these symptoms of anaphylaxis.
There are no known long-term 'toxic' side effects of Artemisia Absinthium Pollen, as it is a natural protein extract. However, the primary long-term risk is the development of new sensitivities, though immunotherapy is generally thought to prevent the development of new allergies (the 'allergic march'). Some patients may experience a persistent nodule at the injection site if the extract is consistently injected into the same location.
While non-standardized extracts may not always carry a formal 'Black Box' on every label, the FDA requires a general warning for all allergenic extracts regarding the risk of severe systemic reactions.
Summary of Warning: Artemisia Absinthium Pollen can cause severe, life-threatening systemic reactions, including anaphylaxis. This product must only be administered by physicians trained in the treatment of anaphylaxis. Patients with unstable asthma are at higher risk for fatal reactions. Patients taking beta-blockers may be resistant to the effects of epinephrine used to treat reactions.
Report any unusual symptoms to your healthcare provider immediately.
Artemisia Absinthium Pollen must be used with extreme caution. The primary safety concern is the risk of a systemic allergic reaction. Because this is a non-standardized extract, the protein concentration can vary between different manufacturers' lots, making careful observation during lot changes essential.
No specific FDA black box warning is unique to Artemisia Absinthium Pollen, but it falls under the mandatory class-wide warnings for allergenic extracts. These warnings emphasize that the product is intended for use only by clinicians experienced in immunotherapy and that emergency equipment (epinephrine, airway management) must be immediately available.
Artemisia Absinthium Pollen does not typically cause sedation. However, if a patient experiences a systemic reaction or receives epinephrine, they should not drive or operate machinery until they have fully recovered and been cleared by a medical professional.
Patients should avoid alcohol consumption for several hours before and after their injection. Alcohol can increase blood flow to the skin and potentially accelerate the absorption of the allergen, increasing the risk of a reaction.
Immunotherapy is typically discontinued if the patient experiences a life-threatening systemic reaction that cannot be managed by dose adjustment. It may also be stopped if no clinical improvement is seen after 12-24 months of maintenance therapy.
> Important: Discuss all your medical conditions with your healthcare provider before starting Artemisia Absinthium Pollen.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Patients allergic to Artemisia Absinthium may also react to other members of the Asteraceae (Compositae) family. This includes:
Healthcare providers should consider this cross-reactivity when designing a multi-allergen immunotherapy program.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Artemisia Absinthium Pollen.
Artemisia Absinthium Pollen is classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women.
It is not known whether the allergenic proteins or their metabolites are excreted in human milk. However, since these are large proteins and the amount injected is very small, it is considered unlikely to affect a nursing infant. The benefits of controlling the mother's allergy symptoms usually outweigh the theoretical risks.
As noted, the safety and efficacy of pollen extracts have been established in children as young as 5 years old. The primary concern in younger children is the inability to articulate the early symptoms of a systemic reaction, such as an itchy throat or a sense of 'impending doom.'
Clinical studies of allergenic extracts often do not include sufficient numbers of subjects aged 65 and over. In older adults, the decision to use Artemisia Absinthium Pollen must take into account the higher prevalence of cardiovascular disease and the potential use of medications like beta-blockers or ACE inhibitors.
Renal impairment does not significantly alter the processing of allergenic extracts. No specific dosage adjustments are typically required, but the patient's general physiological stability should be confirmed.
There is no evidence that hepatic impairment affects the safety or efficacy of subcutaneous immunotherapy. The proteins are processed locally by the immune system.
> Important: Special populations require individualized medical assessment.
Artemisia Absinthium Pollen extract works by inducing immunological tolerance. The primary allergens in the pollen, such as the Art v 1 protein, are captured by dendritic cells at the injection site. These cells present the allergen fragments to T-lymphocytes. In an allergic individual, this usually results in a Th2 response. Immunotherapy redirects this toward a T-regulatory (Treg) response, which secretes IL-10 and TGF-beta. These cytokines suppress IgE production and promote the switch to IgG4, which acts as a 'decoy' antibody.
| Parameter | Value |
|---|---|
| Bioavailability | Low (Subcutaneous localization) |
| Protein Binding | N/A (Processed by immune cells) |
| Half-life | Hours to days (for protein fragments) |
| Tmax | 1-2 hours (for local absorption) |
| Metabolism | Proteolysis by macrophages and APCs |
| Excretion | Not traditionally measured |
Artemisia Absinthium Pollen extract is a complex mixture of proteins, glycoproteins, and polysaccharides. The molecular weight of the major allergens typically ranges from 10 to 70 kDa. It is soluble in buffered saline solutions used for injection. The extract is standardized by its protein nitrogen content (PNU) or by its raw weight-to-volume ratio (w/v).
It is classified as a Non-Standardized Pollen Allergenic Extract. It is related to other extracts like Ragweed, Oak, and Timothy Grass, though its specific protein composition is unique to the Artemisia genus.
Common questions about Artemisia Absinthium Pollen
Artemisia Absinthium Pollen is primarily used for the diagnosis and treatment of seasonal allergies caused by the Wormwood plant. In diagnostic settings, it is used in skin prick tests to confirm if a patient is sensitive to this specific pollen. For treatment, it is used in allergen immunotherapy, commonly known as allergy shots. This involves giving a patient gradually increasing amounts of the pollen extract to desensitize their immune system. Over time, this can significantly reduce symptoms of hay fever, allergic conjunctivitis, and allergic asthma.
The most common side effects are local reactions at the site of the injection, occurring in a majority of patients. These include redness, itching, and swelling of the skin where the shot was given. These reactions are usually mild and disappear within 24 to 48 hours. Some patients may also experience a temporary increase in their usual allergy symptoms, such as sneezing or watery eyes. While rare, more significant swelling (large local reactions) can occur, which may require icing the area or taking an oral antihistamine as directed by a doctor.
It is generally advised to avoid alcohol consumption on the days you receive an Artemisia Absinthium Pollen injection. Alcohol can cause your blood vessels to dilate (widen), which may speed up the absorption of the allergen into your bloodstream. This increased absorption rate can raise the risk of a systemic allergic reaction or anaphylaxis. Furthermore, alcohol can sometimes mask the early symptoms of a reaction, making it harder for you or your healthcare provider to identify a problem. Always consult your allergist about lifestyle restrictions during your treatment.
The safety of starting Artemisia Absinthium Pollen immunotherapy during pregnancy has not been established, and it is generally avoided. The primary concern is not that the extract is toxic to the fetus, but that a severe allergic reaction (anaphylaxis) in the mother could lead to a lack of oxygen for the baby. However, if a woman is already on a stable maintenance dose of allergy shots and becomes pregnant, many healthcare providers will allow her to continue the treatment. The decision is made on a case-by-case basis, weighing the benefits of allergy control against the risks of a reaction.
Allergen immunotherapy is a long-term treatment process and does not provide immediate relief. Most patients begin to notice a significant reduction in their allergy symptoms after they reach their 'maintenance dose,' which usually takes 3 to 6 months of weekly injections. Maximum benefit is typically seen after the first full year of treatment. To achieve long-lasting results that persist even after the shots are stopped, a full course of 3 to 5 years of therapy is usually recommended by clinical guidelines.
Yes, you can stop taking the injections at any time without experiencing withdrawal symptoms, as it is not an addictive medication. However, stopping the treatment before the recommended 3-to-5-year period usually means that your allergy symptoms will eventually return. If you stop during the 'build-up' phase, you will likely see no long-term benefit at all. If you need to pause treatment due to illness or travel, your doctor will need to adjust your next dose downward to ensure safety when you resume.
If you miss a scheduled injection, you should contact your allergist's office as soon as possible to reschedule. Do not attempt to 'double up' on your next dose. If only a few days have passed, your doctor may give you your usual dose. However, if several weeks have passed, your immune system's tolerance may have decreased, and your doctor will likely need to reduce the dose for your next injection to prevent a reaction. Consistency is key to the success of immunotherapy.
There is no clinical evidence to suggest that Artemisia Absinthium Pollen extracts cause weight gain. The extract consists of natural proteins and is administered in very small quantities that do not affect metabolic rate or appetite. If you experience weight changes while on immunotherapy, it is likely due to other factors, such as the use of oral corticosteroids for asthma or other unrelated lifestyle changes. You should discuss any unexpected weight changes with your primary care physician.
Artemisia Absinthium Pollen can be taken with most medications, but there are some critical exceptions. You must inform your doctor if you are taking beta-blockers, ACE inhibitors, or MAO inhibitors, as these can make allergic reactions more dangerous or harder to treat. Most standard allergy medications, like antihistamines and nasal sprays, are fine to continue and may even be encouraged. Always provide your allergist with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are using.
The concept of 'generic' vs. 'brand name' is slightly different for allergenic extracts than for traditional pills. Artemisia Absinthium Pollen is produced by several different biological laboratories (such as ALK, Greer, or HollisterStier). While the extracts are all derived from the same plant species, they are considered 'non-standardized,' meaning the exact protein concentration may vary slightly between manufacturers. Therefore, they are not always interchangeable. Your allergist will typically stick with one manufacturer for your entire course of treatment to ensure consistency.